Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today unveiled the findings from its sixth annual Global Sleep Survey.
Drawing insights from 30,000 people across 13 countries, the survey reveals a widening gap between recognition of sleep's importance and action to improve sleep health. While over half (53%) of respondents rank sleep as the most important contributor to long-term health compared to diet and exercise, many are not taking meaningful steps to improve their sleep quality.
Sleep is increasingly recognized as a key pillar of long-term health1, with 84% of respondents worldwide understanding that consistent, quality sleep can help extend a healthy lifespan. However, awareness has not translated into consistent results. The majority of respondents (53%) report getting a good night's sleep only four nights a week or fewer, highlighting the persistent gap between knowing sleep is critical and being able to prioritize it as part of a healthy lifestyle.
As sleep awareness grows, so does the opportunity to turn intent into action.
The findings suggest a clear opportunity to improve education, screening and diagnosis so more people can identify sleep issues earlier and access pathways to care.
How Daily Life Disrupts Sleep
The survey also highlights the everyday pressures shaping sleep patterns worldwide.
“People are increasingly recognizing sleep as a cornerstone to long-term health, which is encouraging,” said Dr. Carlos Nunez, Chief Medical Officer at Resmed. “But recognition alone is not enough. We need to help people move from awareness to action by addressing everyday barriers and improving access to screening, support and care.”
Are you getting enough sleep? Read the full 2026 Resmed Global Sleep Survey report to learn more about the trends impacting the way we sleep. To assess your sleep health, take our online sleep assessment.
Survey Methodology
Resmed commissioned an independent survey of 30,000 individuals across 13 markets: the United States (5,000), China (5,000), India (5,000), United Kingdom (2,000), Germany (2,000), France (2,000), Australia (1,500), Japan (1,500), Korea (1,500), Brazil (1,500), Poland (1,000), Singapore (1,000), and Mexico (1,000). The survey was developed in partnership with The Sleep Health Foundation (Australia) and The Sleep Charity (UK), leveraging their expertise to help identify and refine key focus areas. Samples within each country were representative of national gender and age distributions. The survey was fielded by Cint from 11 December 2025 to 14 January 2026.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We're relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we're redefining sleep health at Resmed.com and follow @Resmed.
| For Media | For Investors |
| Cassie-Anne Low | Salli Schwartz |
| news@resmed.com | investorrelations@resmed.com |
本文链接:/hangye/53288.html